ANVISA
The new article provides further clarifications on the applicable regulatory requirements, paying special attention to the most important aspects.
ANVISA
The new article highlights certain specific aspects related to the regulatory status of personalised devices allowed for marketing and use in Brazil.
ANVISA
The new article covers the matters related to classification of personalised devices and provides additional clarifications in this respect.
EU
The final article of the cycle is dedicated to combination products and their specific regulatory nature.
EU
The new article further elaborates on the key matters associated with substance-based products intended to be marketed and used within the EU.
Gartner® Market Guide for Life Science Regulatory Information Management Solutions
Download NowGartner® Market Guide for Regulatory Intelligence Solutions
Download Now
